Decoy Therapeutics is trading 5.67% up now at $4.29, based on the provided pre-market quote; no clear August 7, 2026 company-specific catalyst was identified.
- On August 3, 2026, Decoy expanded its intellectual-property portfolio to seven patent families and 19 pending applications.
- That announcement predates the movement; broader markets are only modestly higher, leaving the immediate reason unclear.